Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Johnson & Johnson
Form 13F · Q2 2026

Johnson & Johnson

CIK 200406Filed 2026-08-0613F-HR View the filing on EDGAR ↗
$799M
Reported book value
15
Positions
12
Quarters on record
Top 50
Positions

Johnson & Johnson — holdings

Top 15 positions of 15, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1PTGX Protagonist Therapeutics Inc2.4M+0.0%$300M37.6%
2NBTX Nanobiotix5.6M+0.0%$212M26.5%
3MGTX Meiragtx Hldgs Plc6.6M+0.0%$90M11.2%
4RAPP Rapport Therapeutics Inc1.8M+0.0%$74M9.3%
5CTNM Contineum Therapeutics Inc2.0M+0.0%$32M4.1%
6LEGN Legend Biotech Corp814,586+0.0%$24M2.9%
7CVRX Cvrx Inc4.0M+0.0%$21M2.6%
8XNCR Xencor Inc748,062+0.0%$12M1.5%
9CBRS Cerebras Systems Inc53,586—$12M1.5%
10FATE Fate Therapeutics Inc3.4M+0.0%$9M1.1%
11PRCT Procept Biorobotics Corp357,939+0.0%$8M1.0%
12NMRA Neumora Therapeutics Inc.1.8M+0.0%$3M0.4%
13VOR Vor Biopharma Inc53,732+0.0%$989,2060.1%
14LAB Standard Biotools Inc311,967+0.0%$256,6550.0%
15ACET Adicet Bio Inc22,779+0.0%$196,8110.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.